| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 295DQC67BJ |
| InChI Key | HKQYGTCOTHHOMP-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C16H12O4 |
| Molecular Weight | 268.27 |
| AlogP | 3.17 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 2.0 |
| Polar Surface Area | 59.67 |
| Molecular species | ACID |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 20.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 1
Cytochrome P450 family 1A
Cytochrome P450 1A1
|
- | - | - | - | 11 | |
|
Enzyme
Cytochrome P450
Cytochrome P450 family 1
Cytochrome P450 family 1B
Cytochrome P450 1B1
|
- | - | - | 3700 | ||
|
Enzyme
Hydrolase
|
- | 1370-5040 | - | - | 1 | |
|
Enzyme
Oxidoreductase
|
- | 11000 | - | - | 18 | |
|
Enzyme
Phosphatase
Protein Phosphatase
Tyrosine protein phosphatase
|
- | - | - | - | 10-33 | |
|
Enzyme
|
- | 1370-5040 | - | 3700 | 10-33 | |
|
Secreted protein
|
- | - | 5470 | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC05 family of sodium-dependent glucose transporters
|
- | - | - | - | 75 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 115 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Osteoporosis | 2 | D010024 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 18088 |
| ChEMBL | CHEMBL242341 |
| DrugBank | DB15335 |
| EPA CompTox | DTXSID4022311 |
| FDA SRS | 295DQC67BJ |
| Human Metabolome Database | HMDB0005808 |
| KEGG | C00858 |
| PubChem | 5280378 |
| SureChEMBL | SCHEMBL62915 |
| ZINC | ZINC000018847036 |